Search for other papers by Olga D. Savvidou in
Google Scholar
PubMed
Search for other papers by Panagiotis Koutsouradis in
Google Scholar
PubMed
Search for other papers by George D. Chloros in
Google Scholar
PubMed
Search for other papers by Ioannis Papanastasiou in
Google Scholar
PubMed
Search for other papers by Thomas Sarlikiotis in
Google Scholar
PubMed
Search for other papers by Aggelos Kaspiris in
Google Scholar
PubMed
Search for other papers by Panayiotis J. Papagelopoulos in
Google Scholar
PubMed
Introduction Bone tumours around the elbow are rare and their incidence is approximately 1%. 1 The literature regarding primary bone tumours of the elbow is sparse, with only two case series consisting of 75 patients and 25 patients
Search for other papers by James Plant in
Google Scholar
PubMed
Search for other papers by Stephen Cannon in
Google Scholar
PubMed
Introduction Primary bone tumours are rare, with an incidence in the United Kingdom of around six cases per million of the population. The general orthopaedic surgeon may only encounter one or two in their life’s practice. It is therefore
Search for other papers by Marta Salom in
Google Scholar
PubMed
Search for other papers by Inês Balacó in
Google Scholar
PubMed
Introduction Bone tumours are more common in children than in adults, being the vast majority benign. So, it is common for an orthopaedic surgeon to face his professional career with bone lesions in children that may raise doubts about whether
Search for other papers by Ajay Puri in
Google Scholar
PubMed
tumours can be quite challenging to diagnose, it is best for these lesions to be discussed in a multidisciplinary meeting which includes a radiologist and a pathologist specializing in bone tumours. Mesenchymal chondrosarcoma, an aggressive histological
Search for other papers by Antal Imre in
Google Scholar
PubMed
Search for other papers by Sápi Zoltán in
Google Scholar
PubMed
Search for other papers by Szendrői Miklós in
Google Scholar
PubMed
European Medical Agency (EMA) for GCTB under certain indications (tumours requiring morbid surgery, unresectable or metastatic GCTB). GCTB is defined by the WHO as a locally aggressive, rarely metastasising bone tumour of intermediate dignity ( 4 ). GCTB
These authors contributed equally to this manuscript
Search for other papers by Olga Savvidou in
Google Scholar
PubMed
These authors contributed equally to this manuscript
Search for other papers by Olympia Papakonstantinou in
Google Scholar
PubMed
These authors contributed equally to this manuscript
Search for other papers by Eleftheria Lakiotaki in
Google Scholar
PubMed
Search for other papers by Ioannis Zafeiris in
Google Scholar
PubMed
Search for other papers by Dimitra Melissaridou in
Google Scholar
PubMed
Co-senior authors
Search for other papers by Pinelopi Korkolopoulou in
Google Scholar
PubMed
Co-senior authors
Search for other papers by Panayiotis J. Papagelopoulos in
Google Scholar
PubMed
Introduction Surface bone tumours are neoplasms situated near the bone cortex. They are classified into five different types: osseous, cartilaginous, fibrous, lipomatous and metastatic tumours. The most common types are those producing bone
These authors contributed equally to this manuscript
Search for other papers by Olga Savvidou in
Google Scholar
PubMed
These authors contributed equally to this manuscript
Search for other papers by Olympia Papakonstantinou in
Google Scholar
PubMed
These authors contributed equally to this manuscript
Search for other papers by Eleftheria Lakiotaki in
Google Scholar
PubMed
Search for other papers by Dimitra Melissaridou in
Google Scholar
PubMed
Co-senior authors
Search for other papers by Pinelopi Korkolopoulou in
Google Scholar
PubMed
Co-senior authors
Search for other papers by Panayiotis J. Papagelopoulos in
Google Scholar
PubMed
painless bone tumour Slowly growing bone tumour, occasionally painful Swelling and/or pain, bone tumour Slowly growing soft tissue tumour +/– painful, swelling, decreased ROM Painless, enlarging palpable soft tissue tumour, decreased ROM
Search for other papers by E. Mascard in
Google Scholar
PubMed
Search for other papers by N. Gaspar in
Google Scholar
PubMed
Search for other papers by L. Brugières in
Google Scholar
PubMed
Search for other papers by C. Glorion in
Google Scholar
PubMed
Search for other papers by S. Pannier in
Google Scholar
PubMed
Search for other papers by A. Gomez-Brouchet in
Google Scholar
PubMed
Introduction Benign tumours and tumour-like lesion of the foot and ankle are not uncommon but malignant tumours and especially malignant bone tumours of the foot are rare. Most of the foot tumours are benign: usually synovial cysts (30% of
Search for other papers by Mohsen Raza in
Google Scholar
PubMed
Search for other papers by Daniel Murphy in
Google Scholar
PubMed
St George’s, University of London, London, UK
Search for other papers by Yael Gelfer in
Google Scholar
PubMed
inclusion criteria were: any published original article, use of 3D printing technology, orthopaedic surgery, paediatric primary study population (aged ≤ 16 years). Exclusion criteria were: basic science articles, spinal surgery, bone tumour surgery and
Search for other papers by Maria A. Smolle in
Google Scholar
PubMed
Search for other papers by Dimosthenis Andreou in
Google Scholar
PubMed
Search for other papers by Per-Ulf Tunn in
Google Scholar
PubMed
Search for other papers by Andreas Leithner in
Google Scholar
PubMed
(LDK, Co., Ltd, Haidian, Beijing, China) polypropylene mesh composite (PROLENE® light mesh, Ethicon) after bone tumour resection of the proximal humerus. 5 In that study, a mean MSTS score of 66.7% at last follow-up was reported. 5 In a
